Kintor Pharmaceutical Sets 19 August 2026 Board Meeting to Review 1H26 Interim Results

Bulletin Express

Aug 05

Kintor Pharmaceutical Limited announced that its board of directors will convene on 19 August 2026 to consider and approve the interim results for the six-month period ended 30 June 2026 and to authorize their publication.

The notice, signed by Chairman, Executive Director and Chief Executive Officer Dr. Youzhi Tong, was released in Hong Kong on 5 August 2026.

As of the announcement date, the board comprises: • Executive Directors: Dr. Youzhi Tong and Dr. Xiang Ni • Non-Executive Directors: Mr. Yunfei Chen and Ms. Geqi Wei • Independent Non-Executive Directors: Dr. Michael Min Xu, Mr. Wallace Wai Yim Yeung and Prof. Liang Tong

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1102089831"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1102089831\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1102089831?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 17:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1102089831","market":"us","top_or_hot":-1,"title":"Kintor Pharmaceutical Sets 19 August 2026 Board Meeting to Review 1H26 Interim Results","media":"Bulletin Express","content":"<p>Kintor Pharmaceutical Limited announced that its board of directors will convene on 19 August 2026 to consider and approve the interim results for the six-month period ended 30 June 2026 and to authorize their publication.</p>\n<p>The notice, signed by Chairman, Executive Director and Chief Executive Officer Dr. Youzhi Tong, was released in Hong Kong on 5 August 2026.</p>\n<p>As of the announcement date, the board comprises:\n• Executive Directors: Dr. Youzhi Tong and Dr. Xiang Ni  \n• Non-Executive Directors: Mr. Yunfei Chen and Ms. Geqi Wei  \n• Independent Non-Executive Directors: Dr. Michael Min Xu, Mr. Wallace Wai Yim Yeung and Prof. Liang Tong</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kintor Pharmaceutical Sets 19 August 2026 Board Meeting to Review 1H26 Interim Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKintor Pharmaceutical Sets 19 August 2026 Board Meeting to Review 1H26 Interim Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-05 17:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Kintor Pharmaceutical Limited announced that its board of directors will convene on 19 August 2026 to consider and approve the interim results for the six-month period ended 30 June 2026 and to authorize their publication.</p>\n<p>The notice, signed by Chairman, Executive Director and Chief Executive Officer Dr. Youzhi Tong, was released in Hong Kong on 5 August 2026.</p>\n<p>As of the announcement date, the board comprises:\n• Executive Directors: Dr. Youzhi Tong and Dr. Xiang Ni  \n• Non-Executive Directors: Mr. Yunfei Chen and Ms. Geqi Wei  \n• Independent Non-Executive Directors: Dr. Michael Min Xu, Mr. Wallace Wai Yim Yeung and Prof. Liang Tong</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09939","symbol_name":"开拓药业-B","start_time":0,"source_url":"","article_id":"1102089831","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1102089831","pubTimestamp":1785922570,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Kintor Pharmaceutical Limited announced that its board of directors will convene on 19 August 2026 to consider and approve the interim results for the six-month period ended 30 June 2026 and to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09939":"开拓药业-B"},"translate_title":"开拓药业定于 2026 年 8 月 19 日召开董事会会议，审查 26 年上半年中期业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09939":1},"content_text":"Kintor Pharmaceutical Limited announced that its board of directors will convene on 19 August 2026 to consider and approve the interim results for the six-month period ended 30 June 2026 and to authorize their publication.\nThe notice, signed by Chairman, Executive Director and Chief Executive Officer Dr. Youzhi Tong, was released in Hong Kong on 5 August 2026.\nAs of the announcement date, the board comprises:\n• Executive Directors: Dr. Youzhi Tong and Dr. Xiang Ni  \n• Non-Executive Directors: Mr. Yunfei Chen and Ms. Geqi Wei  \n• Independent Non-Executive Directors: Dr. Michael Min Xu, Mr. Wallace Wai Yim Yeung and Prof. Liang Tong","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}